The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer
Ramón Rami-Porta,Katherine K. Nishimura,Dorothy J. Giroux,Frank Detterbeck,Giuseppe Cardillo,John G. Edwards,Kwun M. Fong,Meredith Giuliani,James Huang,Kemp H. Kernstine,Edith M. Marom,Andrew G. Nicholson,Paul E. Van Schil,William D. Travis,Ming S. Tsao,Shun-Ichi Watanabe,Valerie W. Rusch,Hisao Asamura,and Participating Institutions the Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards
DOI: https://doi.org/10.1016/j.jtho.2024.02.011
IF: 20.121
2024-03-28
Journal of Thoracic Oncology
Abstract:Introduction The TNM classification of lung cancer is periodically revised. The International Association for the Study of Lung Cancer collected and analyzed a new database to inform the forthcoming ninth edition of the TNM classification. The results are herewith presented. Methods After exclusions, 76,518 patients from a total of 124,581 registered patients were available for analyses: 58,193 with clinical stage, 39,192 with pathologic stage, and 62,611 with best stage NSCLC. The proposed new N2 subcategories (N2a, involvement of single ipsilateral mediastinal or subcarinal nodal station, and N2b, involvement of multiple ipsilateral mediastinal nodal stations with or without involvement of the subcarinal nodal station) and the new M1c subcategories (M1c1, multiple extrathoracic metastases in one organ system, and M1c2, multiple extrathoracic metastases in multiple organ systems) were considered in the survival analyses. Several potential stage groupings were evaluated, using multiple analyses, including recursive partitioning, assessment of homogeneity within and discrimination between potential groups, clinical and statistical significance of survival differences, multivariable regression, and broad assessment of generalizability. Results T1N1, T1N2a, and T3N2a subgroups are assigned to IIA, IIB, and IIIA stage groups, respectively. T2aN2b and T2bN2b subgroups are assigned to IIIB. M1c1 and M1c2 remain in stage group IVB. Analyses reveal consistent ordering, discrimination of prognosis, and broad generalizability of the proposed ninth edition stage classification of lung cancer. Conclusions The proposed stages for the ninth edition TNM improve the granularity of nomenclature about anatomic extent that has benefits as treatment approaches become increasingly differentiated and complex.
oncology,respiratory system